SH2D4A is a tumor suppressor protein encoded on chromosome 8 that functions as a multivalent signaling regulator with roles in cell cycle control, mitochondrial function, and immune response. Mechanistically, SH2D4A inhibits estrogen-induced proliferation by competing with PLCG for ESR1 binding and serves as a negative regulator of PP1 phosphatase to promote centrosome maturation and mitotic progression 1. At the mitochondrial level, SH2D4A physically interacts with STAT3 and prohibitins to prevent STAT3 nuclear translocation and transcriptional activity, thereby suppressing pro-tumorigenic signaling 2. SH2D4A also participates in T-cell signal transduction as a member of the T-cell-specific adapter protein family 3. Downregulation of SH2D4A is frequently observed across multiple cancer types due to chromosome 8 deletions and strongly associates with poor prognosis. In esophageal squamous cell carcinoma, SH2D4A suppresses the FAK/PI3K/AKT pathway 4, while in hepatocellular carcinoma and colorectal cancer, it cooperatively inhibits IL-6/STAT3 signaling with SORBS3, promoting T-cell infiltration and immune activation 56. SH2D4A is downregulated in HCC tissues and cirrhotic nodules 7. Beyond tumor suppression, SH2D4A co-regulates triglyceride levels in ruminant meat, indicating broader metabolic functions 8.